Cartilage diseases.

Hyaline cartilages, fibrocartilages and elastic cartilages play multiple roles in the human body including bearing loads in articular joints and intervertebral discs, providing joint lubrication, forming the external ears and nose, supporting the trachea, and forming the long bones during development and growth. The structure and organization of cartilage's extracellular matrix (ECM) are the primary determinants of normal function. Most diseases involving cartilage lead to dramatic changes in the ECM which can govern disease progression (e.g., in osteoarthritis), cause the main symptoms of the disease (e.g., dwarfism caused by genetically inherited mutations) or occur as collateral damage in pathological processes occurring in other nearby tissues (e.g., osteochondritis dissecans and inflammatory arthropathies). Challenges associated with cartilage diseases include poor understanding of the etiology and pathogenesis, delayed diagnoses due to the aneural nature of the tissue and drug delivery challenges due to the avascular nature of adult cartilages. This narrative review provides an overview of the clinical and pathological features as well as current treatment options available for various cartilage diseases. Late breaking advances are also described in the quest for development and delivery of effective disease modifying drugs for cartilage diseases including osteoarthritis, the most common form of arthritis that affects hundreds of millions of people worldwide.

[1]  F. Berenbaum,et al.  Brief Report: A Phase IIb Trial of a Novel Extended‐Release Microsphere Formulation of Triamcinolone Acetonide for Intraarticular Injection in Knee Osteoarthritis , 2017, Arthritis & rheumatology.

[2]  J. Carey,et al.  Treatment algorithm for osteochondritis dissecans of the knee. , 2014, Clinics in sports medicine.

[3]  Thelma Skare,et al.  Jaccoud arthropathy in systemic lupus erythematosus: clinical and serological findings. , 2012, Revista da Associacao Medica Brasileira.

[4]  M. Hochberg,et al.  A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. , 2017, Osteoarthritis and cartilage.

[5]  B. Alman,et al.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets , 2010, Nature Reviews Cancer.

[6]  R. Moots,et al.  The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. , 2012, Autoimmunity reviews.

[7]  H. Gelderblom,et al.  The clinical approach towards chondrosarcoma. , 2008, The oncologist.

[8]  Gorjan Alagic,et al.  #p , 2019, Quantum information & computation.

[9]  P. Guerne,et al.  Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis. , 2007, Arthritis and rheumatism.

[10]  F. C. Linn,et al.  Lubrication of animal joints. I. The arthrotripsometer. , 1967, The Journal of bone and joint surgery. American volume.

[11]  G. Mccarthy,et al.  Treatment and management of pseudogout: insights for the clinician , 2012, Therapeutic advances in musculoskeletal disease.

[12]  P. Beighton,et al.  Spondyloepiphyseal dysplasia, mild autosomal dominant type is not due to primary defects of type II collagen. , 1990, American journal of medical genetics.

[13]  B Schoeberl,et al.  Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis. , 2014, Osteoarthritis and cartilage.

[14]  A. Franchi Epidemiology and classification of bone tumors. , 2012, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[15]  M. Briggs,et al.  The aggrecanopathies; an evolving phenotypic spectrum of human genetic skeletal diseases , 2016, Orphanet Journal of Rare Diseases.

[16]  P. Hammond,et al.  Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term. , 2015, Osteoarthritis and cartilage.

[17]  R. Terkeltaub,et al.  TLR2 Signaling in Chondrocytes Drives Calcium Pyrophosphate Dihydrate and Monosodium Urate Crystal-Induced Nitric Oxide Generation1 , 2005, The Journal of Immunology.

[18]  M. Lotz Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options , 2010 .

[19]  Garry E Gold,et al.  Diagnosis of osteoarthritis: imaging. , 2012, Bone.

[20]  R. Fässler,et al.  Sensing the mechano-chemical properties of the extracellular matrix. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[21]  X. Bai,et al.  Strontium ranelate, a promising disease modifying osteoarthritis drug , 2017, Expert opinion on investigational drugs.

[22]  G. Vawter,et al.  Nonexpression of cartilage type II collagen in a case of Langer-Saldino achondrogenesis. , 1986, American journal of human genetics.

[23]  D. Mccarty The Significance of Calcium Phosphate Crystals in the Synovial Fluid of Arthritic Patients: The Pseudogout Syndrome: I. Clinical Aspects , 1962 .

[24]  R. Russell,et al.  Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals. , 1983, Annals of the rheumatic diseases.

[25]  R. Kosaki,et al.  Identification of COL2A1 mutations in platyspondylic skeletal dysplasia, Torrance type , 2004, Journal of Medical Genetics.

[26]  B. Rothschild,et al.  Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD. , 1997, Comprehensive therapy.

[27]  E. Vignon,et al.  When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program , 2016, Arthritis & rheumatology.

[28]  M. Kocher,et al.  Osteochondritis Dissecans of the Knee , 2015, JBJS reviews.

[29]  PTHrP , 2019, Springer Reference Medizin.

[30]  J CHARNLEY,et al.  The Lubrication of Animal Joints in Relation to Surgical Reconstruction by Arthroplasty * , 1960, Annals of the rheumatic diseases.

[31]  S. Mundlos,et al.  Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development‐transcription factors and signaling pathways 1 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  F. Berenbaum,et al.  Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis , 2012, Osteoporosis International.

[33]  J. Dudhia Aggrecan, aging and assembly in articular cartilage , 2005, Cellular and Molecular Life Sciences CMLS.

[34]  M. Peterson,et al.  Burden of childhood-onset arthritis , 2010, Pediatric rheumatology online journal.

[35]  G. Schulze-Tanzil,et al.  Osteoarthritis and the Complement Cascade , 2018, Clinical medicine insights. Arthritis and musculoskeletal disorders.

[36]  Christine Ortiz,et al.  Time-dependent nanomechanics of cartilage. , 2011, Biophysical journal.

[37]  Kathryn L Bauer,et al.  Management of Osteochondritis Dissecans Lesions of the Knee, Elbow and Ankle. , 2017, Clinics in sports medicine.

[38]  H. Muir,et al.  Proteoglycans as organizers of the intercellular matrix. , 1983, Biochemical Society transactions.

[39]  B. Mandell,et al.  Update on Crystal-Induced Arthritides. , 2017, Clinics in geriatric medicine.

[40]  F. Beier,et al.  Targeting oxidative stress to reduce osteoarthritis , 2016, Arthritis Research & Therapy.

[41]  H. Levine,et al.  Relapsing polychondritis — REPORT OF TEN CASES , 1979, The Laryngoscope.

[42]  D. Heinegård,et al.  A Novel Cartilage Protein (CILP) Present in the Mid-zone of Human Articular Cartilage Increases with Age* , 1998, The Journal of Biological Chemistry.

[43]  C. Alves,et al.  Metaphyseal Condrodysplasia, Schmid-type, a Differential Diagnosis with Rickets , 2010, Journal of pediatric endocrinology & metabolism : JPEM.

[44]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[45]  Sheila Unger,et al.  Nosology and classification of genetic skeletal disorders: 2015 revision , 2015, American journal of medical genetics. Part A.

[46]  P. Guerne,et al.  Treating difficult crystal pyrophosphate dihydrate deposition disease , 2008, Current rheumatology reports.

[47]  W M O'Fallon,et al.  Relapsing polychondritis. Survival and predictive role of early disease manifestations. , 1986, Annals of internal medicine.

[48]  D. Green,et al.  Classification and assessment of juvenile osteochondritis dissecans knee lesions , 2016, Current opinion in pediatrics.

[49]  A. Papavassiliou,et al.  ROS/oxidative stress signaling in osteoarthritis. , 2016, Biochimica et biophysica acta.

[50]  U. Müller-Ladner,et al.  Expression of adipokines in osteoarthritis osteophytes and their effect on osteoblasts. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[51]  F. Eckstein,et al.  Brief Report: Intraarticular Sprifermin Not Only Increases Cartilage Thickness, but Also Reduces Cartilage Loss: Location‐Independent Post Hoc Analysis Using Magnetic Resonance Imaging , 2015, Arthritis & rheumatology.

[52]  M. Heymann,et al.  Biology of Bone Sarcomas and New Therapeutic Developments , 2017, Calcified Tissue International.

[53]  P. Beighton,et al.  A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. , 2005, American journal of human genetics.

[54]  M. Karsdal,et al.  Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future. , 2016, Osteoarthritis and cartilage.

[55]  J. Polousky,et al.  Salvage techniques in osteochondritis dissecans. , 2014, Clinics in sports medicine.

[56]  A. Grodzinsky,et al.  Electrostatic interactions enable rapid penetration, enhanced uptake and retention of intra‐articular injected avidin in rat knee joints , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[57]  V. Kraus,et al.  The Role of Innate Immunity in Osteoarthritis: When Our First Line of Defense Goes On the Offensive , 2015, The Journal of Rheumatology.

[58]  P. Mishra,et al.  Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system. , 2017, Osteoarthritis and cartilage.

[59]  A. Haj-Mirzaian,et al.  Bisphosphonates intake and its association with changes of periarticular bone area and three-dimensional shape: data from the Osteoarthritis Initiative (OAI). , 2018, Osteoarthritis and cartilage.

[60]  G. Dubyak,et al.  The progressive ankylosis gene product ANK regulates extracellular ATP levels in primary articular chondrocytes , 2013, Arthritis Research & Therapy.

[61]  H. Haubeck Aggrecan , 2019, Springer Reference Medizin.

[62]  N. Lane,et al.  Osteoarthritis in 2016: Anti-NGF treatments for pain — two steps forward, one step back? , 2017, Nature Reviews Rheumatology.

[63]  M. Klein-Gitelman,et al.  An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus , 2016, Rheumatology and Therapy.

[64]  Marie-Christine Chaboissier,et al.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. , 2002, Genes & development.

[65]  M. Walter,et al.  Genetic study of SOX9 in a case of campomelic dysplasia. , 2001, American journal of medical genetics.

[66]  M. Doherty,et al.  Gout. Epidemiology of gout , 2010, Arthritis Research & Therapy.

[67]  Arnold Munnich,et al.  Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.

[68]  B. Daly,et al.  Overview of epidemiology , 2013 .

[69]  Yang Wang,et al.  Intra‐articular dexamethasone to inhibit the development of post‐traumatic osteoarthritis , 2017, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[70]  J. Polousky,et al.  A Review of Knowledge in Osteochondritis Dissecans: 123 Years of Minimal Evolution from König to the ROCK Study Group , 2013, Clinical orthopaedics and related research.

[71]  Changqing Zhang,et al.  Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes , 2013, Arthritis Research & Therapy.

[72]  Muhammad Asim Khan,et al.  Update on Spondyloarthropathies , 2002, Annals of Internal Medicine.

[73]  A. Grodzinsky,et al.  Quantitative proteomics analysis of cartilage response to mechanical injury and cytokine treatment. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[74]  D. Danks,et al.  Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine. , 1979, Journal of medical genetics.

[75]  T. Hardingham,et al.  Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  H. A. T. Fairbank Osteo‐chondritis dissecans , 1933 .

[77]  A. Boskey,et al.  Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro. , 1992, Arthritis and rheumatism.

[78]  D. Trentham,et al.  Relapsing Polychondritis , 1998, Annals of Internal Medicine.

[79]  A. Mikos,et al.  Strategies for controlled delivery of biologics for cartilage repair. , 2015, Advanced drug delivery reviews.

[80]  Peter G. Schultz,et al.  A Stem Cell–Based Approach to Cartilage Repair , 2012, Science.

[81]  Peter D Kent,et al.  Relapsing polychondritis. , 2004, Current opinion in rheumatology.

[82]  K. Muir,et al.  UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte , 2003, Annals of the rheumatic diseases.

[83]  M. Karsdal,et al.  Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo , 2017, Journal of Translational Medicine.

[84]  O. Akgul,et al.  Classification criteria for spondyloarthropathies. , 2011, World journal of orthopedics.

[85]  C. Pearson,et al.  RELAPSING POLYCHONDRITIS: Prospective Study of 23 Patients and A Review of the Literature , 1976, Medicine.

[86]  N Maffulli,et al.  Physeal injuries in children’s and youth sports: reasons for concern? , 2006, British Journal of Sports Medicine.

[87]  B Lindén,et al.  The incidence of osteochondritis dissecans in the condyles of the femur. , 1976, Acta orthopaedica Scandinavica.

[88]  B. Zabel,et al.  Survival to adulthood and dominant inheritance of platyspondylic skeletal dysplasia, Torrance-Luton type , 2003, Pediatric Radiology.

[89]  H. Schumacher,et al.  Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. , 2003, Osteoarthritis and cartilage.

[90]  F. C. Linn Lubrication of Animal Joints , 1969 .

[91]  M. Bawendi,et al.  Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis. , 2014, Biomaterials.

[92]  D. Heinegård,et al.  Two novel matrix proteins isolated from articular cartilage show wide distributions among connective tissues. , 1986, The Journal of biological chemistry.

[93]  Hyon K. Choi,et al.  Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. , 2011, Arthritis and rheumatism.

[94]  B. Crombrugghe,et al.  Toward understanding SOX9 function in chondrocyte differentiation. , 1998 .

[95]  A. Maroudas,et al.  Transport of solutes through cartilage: permeability to large molecules. , 1976, Journal of anatomy.

[96]  D. Strickland,et al.  MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1 , 2016, Matrix biology : journal of the International Society for Matrix Biology.

[97]  Ali Guermazi,et al.  Advances in imaging of osteoarthritis and cartilage. , 2011, Radiology.

[98]  A. Rosenthal,et al.  Calcium Pyrophosphate Deposition Disease. , 2016, The New England journal of medicine.

[99]  D. Hunter,et al.  Monoclonal antibodies for the treatment of osteoarthritis , 2016, Expert opinion on biological therapy.

[100]  D. Caborn,et al.  Articular Cartilage Changes Seen With Magnetic Resonance Imaging-Detected Bone Bruises Associated With Acute Anterior Cruciate Ligament Rupture , 1998, The American journal of sports medicine.

[101]  A. Cleton-Jansen,et al.  Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. , 2005, The Lancet. Oncology.

[102]  A. Grodzinsky,et al.  Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis. , 2017, European cells & materials.

[103]  J. Elisseeff,et al.  Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment , 2017, Nature Medicine.

[104]  J. Sokolove,et al.  Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations , 2013, Therapeutic advances in musculoskeletal disease.

[105]  C. Jorcyk,et al.  Endoplasmic Reticulum Stress and Unfolded Protein Response in Cartilage Pathophysiology; Contributing Factors to Apoptosis and Osteoarthritis , 2017, International journal of molecular sciences.

[106]  S. Patterson,et al.  Mechanisms and models of endoplasmic reticulum stress in chondrodysplasia , 2014, Developmental dynamics : an official publication of the American Association of Anatomists.

[107]  J. Reveille Epidemiology of Spondyloarthritis in North America , 2011, The American journal of the medical sciences.

[108]  J. Vaněk Spondyloepiphyseal dysplasia. , 1983, Journal of medical genetics.

[109]  A. Fabre,et al.  Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies , 2016, Human mutation.

[110]  J. Ogden Skeletal Growth Mechanism Injury Patterns , 1982, Journal of pediatric orthopedics.

[111]  B. Olsen,et al.  A type X collagen mutation causes Schmid metaphyseal chondrodysplasia , 1993, Nature Genetics.

[112]  S. Mundlos,et al.  Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development‐matrix components and their homeostasis , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[113]  J. J. Butler,et al.  The high prevalence of pathologic calcium crystals in pre-operative knees. , 2002, The Journal of rheumatology.

[114]  S. Nelson,et al.  A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan. , 2009, American journal of human genetics.

[115]  D. Mccarty,et al.  The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals. , 1962, Annals of internal medicine.

[116]  A Ratcliffe,et al.  Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. , 1992, Biomaterials.

[117]  D. Gladman,et al.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome , 2005, Annals of the rheumatic diseases.

[118]  Daniel Cuestas,et al.  Relapsing polychondritis, an underestimated dermatological urgency: case report and literature review , 2017, International journal of dermatology.

[119]  G. Lyritis,et al.  Strontium Ranelate , 2006, Annals of the New York Academy of Sciences.

[120]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[121]  P. Leder,et al.  Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.

[122]  David T Felson,et al.  Updated Estimates Suggest a Much Higher Prevalence of Arthritis in United States Adults Than Previous Ones , 2018, Arthritis & rheumatology.

[123]  J. Hood,et al.  A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. , 2018, Osteoarthritis and cartilage.

[124]  C. Hughes Kinesiology: The Mechanics and Pathomechanics of Human Movement , 2004 .

[125]  M. Kocher,et al.  Drilling techniques for osteochondritis dissecans. , 2014, Clinics in sports medicine.

[126]  S. Majumdar,et al.  Kartogenin treatment prevented joint degeneration in a rodent model of osteoarthritis: A pilot study , 2016, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[127]  B. Olsen,et al.  Collagen IX. , 1997, The international journal of biochemistry & cell biology.

[128]  James A. Martin,et al.  Post‐traumatic osteoarthritis: Improved understanding and opportunities for early intervention , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[129]  M. Nevitt,et al.  Biomarkers for osteoarthritis: current position and steps towards further validation. , 2014, Best practice & research. Clinical rheumatology.

[130]  W. Knudson,et al.  CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention. , 2016, Matrix biology : journal of the International Society for Matrix Biology.

[131]  F. Guilak,et al.  The structure and function of the pericellular matrix of articular cartilage. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[132]  Ryan P. Russell,et al.  The enthesis: a review of the tendon-to-bone insertion. , 2014, Muscles, ligaments and tendons journal.

[133]  J. Ralphs,et al.  Fibrocartilage in tendons and ligaments — an adaptation to compressive load , 1998, Journal of anatomy.

[134]  P. Maroteaux,et al.  Homozygous achondroplasia: morphologic and biochemical study of cartilage. , 1990, American journal of medical genetics.

[135]  Tamás Vicsek,et al.  A nationwide study of the epidemiology of relapsing polychondritis , 2016, Clinical epidemiology.

[136]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[137]  Takako Sasaki,et al.  A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. , 2010, American journal of human genetics.

[138]  A. Poole Osteoarthritis as a Whole Joint Disease , 2012, HSS journal : the musculoskeletal journal of Hospital for Special Surgery.

[139]  D. Eyre,et al.  Articular cartilage collagen: an irreplaceable framework? , 2006, European cells & materials.

[140]  J P Green Osteochondritis dissecans of the knee. , 1966, The Journal of bone and joint surgery. British volume.

[141]  J. Foidart,et al.  Antibodies to type II collagen in relapsing polychondritis. , 1978, The New England journal of medicine.

[142]  Steven F. Isenberg Relapsing Polychondritis , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[143]  R. Boot-Handford,et al.  The unfolded protein response and its relevance to connective tissue diseases , 2009, Cell and Tissue Research.

[144]  C. Helmick,et al.  Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004. , 2007, Arthritis and rheumatism.

[145]  P. Roughley Articular cartilage and changes in arthritis: Noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage , 2001, Arthritis research.

[146]  F. Berenbaum,et al.  Osteoarthritis: an update with relevance for clinical practice , 2011, The Lancet.

[147]  M. Santiago,et al.  Jaccoud Arthropathy in Systemic Lupus Erythematosus: Analysis of Clinical Characteristics and Review of the Literature , 2008, Medicine.

[148]  L. Miller,et al.  Open Access Journal of Sports Medicine Dovepress Post-traumatic Knee Osteoarthritis in the Young Patient: Therapeutic Dilemmas and Emerging Technologies , 2022 .

[149]  S. Shiokawa,et al.  Clonal analysis of B cells in the osteoarthritis synovium , 2001, Annals of the rheumatic diseases.

[150]  W. Kannel,et al.  The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. , 1989, The Journal of rheumatology.

[151]  F. Konig The Classic: On Loose Bodies in the Joint , 2013 .

[152]  Kristina Buac,et al.  Pseudogout-Associated Inflammatory Calcium Pyrophosphate Dihydrate Microcrystals Induce Formation of Neutrophil Extracellular Traps , 2013, The Journal of Immunology.

[153]  R. Iozzo,et al.  A current view of perlecan in physiology and pathology: A mosaic of functions. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[154]  P. Aichroth OSTEOCHONDRITIS DISSECANS OF THE KNEE: A Clinical Survey , 1971 .

[155]  J. Healey,et al.  Cartilage Tumors: Evaluation and Treatment , 2000, The Journal of the American Academy of Orthopaedic Surgeons.

[156]  D. Veale Psoriatic arthritis: recent progress in pathophysiology and drug development , 2013, Arthritis Research & Therapy.

[157]  F. Breedveld,et al.  Susceptibility to relapsing polychondritis is associated with HLA-DR4. , 1993, Arthritis and rheumatism.

[158]  J. Jurvelin,et al.  A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis. , 2016, Clinical and experimental rheumatology.

[159]  T. Aigner,et al.  Immunolocalization of matrix proteins in different human cartilage subtypes. , 2006, Histology and histopathology.

[160]  R. Terkeltaub,et al.  Emerging regulators of the inflammatory process in osteoarthritis , 2015, Nature Reviews Rheumatology.

[161]  First in Human , 2020, Definitions.

[162]  G. Shaw,et al.  The population‐based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US , 2008, American journal of medical genetics. Part A.

[163]  W. Robert Harris,et al.  Injuries Involving the Epiphyseal Plate , 1963 .

[164]  P. Patwari,et al.  Individual cartilage aggrecan macromolecules and their constituent glycosaminoglycans visualized via atomic force microscopy. , 2003, Journal of structural biology.

[165]  R. Schenck,et al.  Current Concept Review - Osteochondritis Dissecans* , 1996 .

[166]  A. Rosenthal,et al.  Parallel regulation of extracellular ATP and inorganic pyrophosphate: Roles of growth factors, transduction modulators, and ANK , 2011, Connective tissue research.

[167]  M. Dougados,et al.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. , 1991, Arthritis and rheumatism.

[168]  A. Gibofsky,et al.  Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. , 2012, The American journal of managed care.

[169]  L. Dodd,et al.  The Clinical Management of Chondrosarcoma , 2009, Current treatment options in oncology.

[170]  E. Maverakis,et al.  Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. , 2017, Journal of autoimmunity.

[171]  G. Mortier,et al.  Dominant negative mutations in the C‐propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies , 2005, American journal of medical genetics. Part A.

[172]  Martin Michaelis,et al.  Osteoarthritis — an untreatable disease? , 2005, Nature Reviews Drug Discovery.

[173]  D. Heinegård,et al.  Matrix proteins bound to associatively prepared proteoglycans from bovine cartilage. , 1979, The Biochemical journal.

[174]  Thomas D Brown,et al.  Posttraumatic Osteoarthritis: A First Estimate of Incidence, Prevalence, and Burden of Disease , 2006, Journal of orthopaedic trauma.

[175]  Alberto Martini,et al.  Juvenile Idiopathic Arthritis , 2000, The Lancet.

[176]  L. Setton,et al.  Progress in intra-articular therapy , 2014, Nature Reviews Rheumatology.

[177]  L. Wenger,et al.  Induction of Matrix Metalloproteinase-8 in Human Fibroblasts by Basic Calcium Phosphate and Calcium Pyrophosphate Dihydrate Crystals: Effect of Phosphocitrate , 2001, Connective tissue research.

[178]  Jeffrey B. Driban,et al.  Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial , 2017, JAMA.

[179]  A. Grodzinsky,et al.  Age-related nanostructural and nanomechanical changes of individual human cartilage aggrecan monomers and their glycosaminoglycan side chains. , 2012, Journal of structural biology.

[180]  Duncan Dowson,et al.  The Frictional Behavior of Human Synovial Joints—Part I: Natural Joints , 1975 .

[181]  I. Shapiro,et al.  Syndecan-4 in intervertebral disc and cartilage: Saint or synner? , 2016, Matrix biology : journal of the International Society for Matrix Biology.

[182]  C. Shu,et al.  The cartilage extracellular matrix as a transient developmental scaffold for growth plate maturation. , 2016, Matrix biology : journal of the International Society for Matrix Biology.

[183]  J. Yates,et al.  Clinical and molecular genetics of Stickler syndrome , 1999, Journal of medical genetics.

[184]  A. Rosenthal,et al.  Metabolism of extracellular pyrophosphate. , 2003, Current opinion in rheumatology.

[185]  W. B. van den Berg,et al.  The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. , 2010, Arthritis and rheumatism.

[186]  Gregory Choy An update on the treatment options for gout and calcium pyrophosphate deposition , 2005, Expert opinion on pharmacotherapy.

[187]  D Dowson,et al.  Some new evidence on human joint lubrication. , 1975, Annals of the rheumatic diseases.

[188]  E. Schipani,et al.  PTHrP, PTH, and the PTH/PTHrP receptor in endochondral bone development. , 2003, Birth defects research. Part C, Embryo today : reviews.

[189]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[190]  König,et al.  Ueber freie Körper in den Gelenken , 1888, Deutsche Zeitschrift für Chirurgie.

[191]  S. Mundlos,et al.  An alpha 1(II) Gly913 to Cys substitution prevents the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage from a patient with hypochondrogenesis. , 1996, American journal of medical genetics.

[192]  M. Englund,et al.  Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)--a cross-sectional analysis. , 2012, Osteoarthritis and cartilage.

[193]  L. Soslowsky,et al.  Decorin and biglycan are necessary for maintaining collagen fibril structure, fiber realignment, and mechanical properties of mature tendons. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[194]  Y. Tegner,et al.  Familial osteochondritis dissecans associated with early osteoarthritis and disproportionate short stature. , 2008, Osteoarthritis and cartilage.

[195]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[196]  D. Heinegård,et al.  Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. , 1992, The Journal of biological chemistry.

[197]  M. Díaz-Almirón,et al.  Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria—A Follow-Up , 2016, Journal of oncology.

[198]  R. Sanmartí,et al.  Prevalence of articular chondrocalcinosis in elderly subjects in a rural area of Catalonia. , 1993, Annals of the rheumatic diseases.

[199]  Matthias Schneider,et al.  Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. , 2003, Arthritis and rheumatism.

[200]  F. Salvo,et al.  Does paracetamol still have a future in osteoarthritis? , 2016, The Lancet.

[201]  N. Bottini,et al.  Polyethylene-glycol-modified single-walled carbon nanotubes for intra-articular delivery to chondrocytes. , 2014, ACS nano.

[202]  Alan J. Grodzinsky,et al.  Cartilage-targeting drug delivery: can electrostatic interactions help? , 2017, Nature Reviews Rheumatology.

[203]  Nicole Gerwin,et al.  Intraarticular drug delivery in osteoarthritis. , 2006, Advanced drug delivery reviews.

[204]  K. Shea,et al.  The Demographics and Epidemiology of Osteochondritis Dissecans of the Knee in Children and Adolescents , 2014, The American journal of sports medicine.

[205]  G. Herrero-Beaumont,et al.  TLR4 signalling in osteoarthritis—finding targets for candidate DMOADs , 2015, Nature Reviews Rheumatology.

[206]  J. Weiss,et al.  Osteochondritis dissecans of the knee: pathoanatomy, epidemiology, and diagnosis. , 2014, Clinics in sports medicine.

[207]  D. Eyre Articular cartilage and changes in Arthritis: Collagen of articular cartilage , 2001, Arthritis research.

[208]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[209]  E. Schipani,et al.  Molecular mechanisms of endochondral bone development. , 2005, Biochemical and biophysical research communications.

[210]  Eric W Edmonds,et al.  Osteochondritis Dissecans: Editorial Comment , 2013, Clinical orthopaedics and related research.

[211]  J O S E P,et al.  Biomechanics of cartilage , 2013 .

[212]  D. Fox,et al.  Advances in the medical treatment of rheumatoid arthritis. , 2011, Hand clinics.

[213]  D. Church,et al.  Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia , 1994, Cell.

[214]  P. Guerne,et al.  Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial , 2014, Arthritis Research & Therapy.

[215]  C. Platsoucas,et al.  The role of T cells in the pathogenesis of osteoarthritis. , 2007, Arthritis and rheumatism.

[216]  V. Wilairatana,et al.  Comparison of characteristics of patients with and without calcium pyrophosphate dihydrate crystal deposition disease who underwent total knee replacement surgery for osteoarthritis. , 2007, Osteoarthritis and cartilage.

[217]  S. Carr,et al.  The extracellular matrix: Tools and insights for the "omics" era. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[218]  R. Stockwell The cell density of human articular and costal cartilage. , 1967, Journal of anatomy.

[219]  Gregory D Jay,et al.  The biology of lubricin: near frictionless joint motion. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[220]  P. Roughley,et al.  The structure and function of cartilage proteoglycans. , 2006, European cells & materials.

[221]  E. Hohenester,et al.  Structural and functional analysis of two small leucine-rich repeat proteoglycans, fibromodulin and chondroadherin , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[222]  Simon W. Jones,et al.  Developing anti-inflammatory therapeutics for patients with osteoarthritis , 2016, Rheumatology.

[223]  Hyon K. Choi,et al.  Psoriatic arthritis epidemiology , 2007, Current rheumatology reports.

[224]  J. Kay,et al.  Evolution of treatment for rheumatoid arthritis. , 2012, Rheumatology.

[225]  H. Kronenberg,et al.  Developmental regulation of the growth plate , 2003, Nature.

[226]  A. Winterpacht,et al.  The type II collagenopathies: A spectrum of chondrodysplasias , 1994, European Journal of Pediatrics.

[227]  Aman Sharma,et al.  Relapsing polychondritis: a review , 2013, Clinical Rheumatology.

[228]  F. Eckstein,et al.  Intraarticular Sprifermin (Recombinant Human Fibroblast Growth Factor 18) in Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 2014, Arthritis & rheumatology.

[229]  S. Mundlos,et al.  A COL2A1 Mutation in Achondrogenesis Type II Results in the Replacement of Type II Collagen by Type I and III Collagens in Cartilage (*) , 1995, The Journal of Biological Chemistry.

[230]  P. Marie,et al.  FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. , 2002, Genes & development.

[231]  K. Kalunian,et al.  New developments in osteoarthritis. , 2005, Clinics in geriatric medicine.